CCR6 and inflammatory bowel disease: A study by Godefroy et al. [30] suggested that DP8α cells (among them, DP8α T cells, including F. prausnitzii-specific T cells have been recognized) co-expressing CCR6 and CXCR6 cause a decrease in inflammation in inflammatory bowel disease (IBD) patients.